亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Primary Embolization of Cerebral Arteriovenous Malformations With Intention to Cure: A Systematic Review of Literature and Meta-Analysis

医学 栓塞 放射外科 动静脉畸形 荟萃分析 外科 放射科 放射治疗 内科学
作者
Nisha Dabhi,Jennifer D. Sokolowski,Mario Zanaty,Ryan T. Kellogg,Min S. Park,Panagiotis Mastorakos
出处
期刊:Neurosurgery [Oxford University Press]
被引量:2
标识
DOI:10.1227/neu.0000000000003001
摘要

BACKGROUND AND OBJECTIVES: The treatment of brain arteriovenous malformations (AVMs) involves multiple approaches, including embolization, microsurgical resection, and radiosurgery. With the advent of new embolisates, dual-lumen balloon catheters, detachable tip microcatheters, and transvenous embolization, endovascular AVM obliteration has become more effective. Although adjuvant embolization and embolization are commonly used, the safety and effectiveness of curative embolization remain unclear. METHODS: We conducted a systematic literature review using PubMed, Ovid Medline, and Web of Science to identify studies reporting outcomes in patients with AVMs who underwent primary embolization with the intention to cure. We collected data on patient characteristics, AVM features, complications, and radiographic and clinical outcomes for meta-analysis. RESULTS: We identified 25 studies with a total of 1425 patients with 1427 AVMs who underwent curative embolization. Of these patients, 70% were low grade (pooled = 61% [39-82]), 67% were <3 cm (pooled = 78% [60-92]), and 75% were in superficial locations (pooled = 80% [72-86]). At last radiographic follow-up (mean, 16.7 ± 10.9 months), the full obliteration rate was 52% (pooled = 61% [43-77]) and retreatment rate was 25% (pooled = 17% [8.3-27]). At last clinical follow-up (mean, 24.2 ± 13.3 months), the poor clinical outcome rate was 7.9% (pooled = 4.4% [1.3-8.7]) and symptomatic complication rate was 13% (pooled = 13% [8-19]). There was no significant difference in the rate of radiographic cure, need for retreatment, and poor outcomes between ruptured and unruptured AVMs. Symptomatic complications were more common in the treatment of unruptured AVMs. The primary outcomes showed high heterogeneity (I 2 = 72%-94%). CONCLUSION: Curative embolization of AVM is primarily reserved for small and low-grade AVMs, with highly variable outcomes. Our findings suggest poor radiographic outcomes and increased risk of complications. Outcomes are highly dependent on patient selection and technique used. Large multicenter prospective studies are required to further guide patient selection, categorize clinical and radiographic outcomes, and identify subgroup of patients that may benefit from curative embolization.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
林夕完成签到 ,获得积分10
1秒前
1秒前
懒癌晚期完成签到,获得积分10
8秒前
选波发布了新的文献求助10
8秒前
寻道图强应助清爽的以晴采纳,获得60
20秒前
ding应助选波采纳,获得10
25秒前
25秒前
陳.发布了新的文献求助10
31秒前
情怀应助陳.采纳,获得10
35秒前
小马甲应助陳.采纳,获得10
35秒前
FashionBoy应助陳.采纳,获得10
35秒前
田様应助陳.采纳,获得10
35秒前
张皓关注了科研通微信公众号
41秒前
科研通AI6应助大气的山彤采纳,获得30
43秒前
59秒前
1分钟前
1分钟前
1分钟前
1分钟前
情怀应助科研通管家采纳,获得30
1分钟前
lgy发布了新的文献求助30
1分钟前
dawnfrf应助半城烟火采纳,获得30
1分钟前
spy完成签到,获得积分10
1分钟前
1分钟前
小小应助司空天德采纳,获得10
2分钟前
感动的醉波完成签到,获得积分10
2分钟前
852应助lgy采纳,获得20
2分钟前
tubby发布了新的文献求助10
2分钟前
在水一方应助tubby采纳,获得10
2分钟前
sy发布了新的文献求助20
2分钟前
2分钟前
2分钟前
2分钟前
sy发布了新的文献求助10
2分钟前
充电宝应助sy采纳,获得10
2分钟前
2分钟前
选波发布了新的文献求助10
3分钟前
彭于晏应助积极的初南采纳,获得10
3分钟前
顾矜应助积极的初南采纳,获得10
3分钟前
ptang发布了新的文献求助10
3分钟前
高分求助中
From Victimization to Aggression 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Reproduction Third Edition 3000
Comprehensive Methanol Science Production, Applications, and Emerging Technologies 2000
化妆品原料学 1000
1st Edition Sports Rehabilitation and Training Multidisciplinary Perspectives By Richard Moss, Adam Gledhill 600
小学科学课程与教学 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5644657
求助须知:如何正确求助?哪些是违规求助? 4764996
关于积分的说明 15025471
捐赠科研通 4803014
什么是DOI,文献DOI怎么找? 2567837
邀请新用户注册赠送积分活动 1525425
关于科研通互助平台的介绍 1484958